Future Food, Future Medicine, Biorevolution
Louise von Stechow
Epsiode 38: Out of the Lab, Into the Code: An ...

For Episode 38 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow discuss the benefits and challenges of AI co-scientists, which can condense the work of weeks, months, or even years of reading, debate, and hour-long lab meetings into minutes.

Researchers at Stanford University and Google DeepMind have released multi-agent AI “scientist” systems. But how good are they, really, and will they overcome current limitations of large language models like OpenAI’s GPT or Google’s Gemini—such as the lack of robust reasoning capabilities, which are crucial for scientific discovery?

Epsiode 38: Out of the Lab, Into the Code: An Age of AI Scientists?
Future Food, Future Medicine, Biorevolution
Louise von Stechow
Epsiode 37: Medical machines get smarter - AI ...

For Episode 37 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by joined by Julian Beimes, AI in MedTech expert at idalab, to explore how Artificial Intelligence (AI) is transforming the MedTech industry, from AI-powered imaging to smart diagnostics and remote monitoring.

Epsiode 37: Medical machines get smarter - AI in Medtech
Biorevolution, Artificial Intelligence, Future Food
Louise von Stechow
Epsiode 36: We are what we eat – The future of ...

For Episode 36 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by Lia Carlucci, CEO of Food campus Berlin to discuss the future of food from alternative proteins and personalized nutrition and how the technologies of the BioRevolution, such as genomics and glucose sensing can aid those efforts.

Epsiode 36: We are what we eat – The future of food
Biorevolution, Artificial Intelligence
Louise von Stechow
Epsiode 35: New tech, new talent, new ...

For Episode 35 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by idalab founder Paul von Bünau to discuss leadership in the age of AI, touching on the potential of AI for biotech and how leaders can adapt processes and help their staff adapt to the new challenges that AI will bring and dive into the question if AI has the potential to make us better leaders.

Epsiode 35: New tech, new talent, new challenges – pharma leadership in the age of AI
Biorevolution
Louise von Stechow
Illuminating the Dark Genome – New Insights ...

For Episode 33 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by CTO and co-founder of Berlin-based biotech LUCID Genomics, Dr. Hossein Moeinzadeh, to discuss the exciting field of non-coding DNA and how LUCID’s AI algorithm can help make sense of non-coding DNA — and how this could improve diagnoses of rare diseases and beyond.

Illuminating the Dark Genome – New Insights into the Genetic Basis of Disease

Biorevolution

,

Epsiode 23: New biotechnologies: revolution or evolution?

,
Epsiode 23: New biotechnologies: revolution or evolution?

A revolution driven by novel biotechnologies (gene editing, neuroprosthetics, synthetic biology, and artificial intelligence in biotech) has the potential to not only change the way we live but the very foundations of our lives – our biology.

But is the so-called biorevolution a real "scientific revolution"?

In the new episode of "We're Doomed, We're Saved," Andreas Horchler and Louise von Stechow look at the biorevolution from different angles, examining its transformative potential and comparing it to revolutions that came before.